Similar Articles
931 Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma
932 Correlation of magnetic resonance signal characteristics and perfusion parameters assessed by volume perfusion computed tomography in hepatocellular carcinoma: Impact on lesion characterization
933 Diabetes mellitus and metformin in hepatocellular carcinoma
934 Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?
935 Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma
936 Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C
937 Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases
938 Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation
939 Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma
940 Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA